Objective: To compare the clinical effect of a new type of nasal feeding device and the commonly used nasal feeding device at present. Methods: From January 2017 to December 2017, 162 cases of acute severe pancreatitis in the General surgery department two in First Hospital of Lanzhou University were treated with enteral nutrition. According to the random number table method, it was divided into experimental group (82 cases) and control group (80 cases). The experimental group used a new nasal feeding device to implement nasogastric nutrition, while the control group used traditional clinical common devices. The evaluation indexes were as follows: comparison of nasal feeding, comfort (abdominal distention), incidence of diarrhea, effect of nasal feeding and convenience of patients' family members. Results: The number of the evaluation of medical staff was not good, general, good and very good were 3, 3, 27 and 49 cases in the experimental group and 4, 48, 15 and 13 cases in the control group, respectively. There was significant difference between the two groups (Z=-7.14, P=0.00). The number of the evaluation of the patients and their families was not good, general, good and very good were 0, 1, 33 and 48 cases in the experimental group and 34, 31, 11 and 4 cases in the control group, respectively. There were significant differences between the two groups (Z=-7.44, P=0.00). The number of severe abdominal distension, general abdominal distension and no abdominal distension were 22, 42 and 18 cases in the experimental group, 43, 34 and 3 cases in the control group, respectively. There were significant differences between the two groups (Z=-4.14, P=0.00). The number of severe diarrhea, general diarrhea and no diarrhea were 8, 50 and 24 cases in the experimental group, 43, 34 and 3 cases in the control group, respectively. There were significant differences between the two groups (Z=-6.55, P=0.00). The number of inconvenience, general and convenience were 2, 5 and 75 cases in the experimental group, and 18, 43 and 19 cases in the control group, respectively. There was significant difference between the two groups (Z=-8.45, P=0.00). Conclusions The new type of nasal feeding device has good performance and safety. The doctor, nurse and patient have good satisfaction, high evaluation, good convenience and suitable for clinical use.

Objective:To evaluate the effect of transitional care on the quality of life of patients with pancreatitis.Methods:We searched the following databases such as PubMed, Web of Science, Cochrane Library, CNKI, CBM, and WanFang Data electronically. Other sources as applying were also retrieved. Comprehensive collection of continuing care on the quality of life in patients with pancreatitis related research. According to the evaluation method of Cochrane system, the quality evaluation and data extraction were carried out, and the RevMan 5.3 software was used for Meta analysis.Results:A total of 21 randomized controlled trials involving 1 818 patients (910/908) were included. SF-36 health survey scale, analysis of 8 Meta subgroups showed that all groups P<0.05, and the combined effect was statistically significant. The results of the intervention with telephone as the main outcome indicator were: maintaining a regular lifestyle [weight mean difference ( WMD) value was 4.33, 95% confidence interval ( CI)2.52-7.44, P<0.01], quitting smoking and drinking ( WMD value was 5.95, 95% CI 3.69-9.59, P<0.01), maintaining a healthy diet ( WMD value was 8.62, 95% CI 5.07-9.59, P<0.01). Continuous nursing based on telephone intervention can reduce the recurrence rate ( WMD value was 0.20, 95% CI 0.13-0.31, P<0.01). Meta-analysis based on the intervention of establishing archives for continuous nursing showed that WMD value was 0.25, 95% CI 0.12-0.52, P<0.01, and archives and telephone showed that WMD value was 0.24, 95% CI 0.09-0.63, P=0.004, and the combined effect was statistically significant. Conclusions:Continuous nursing can improve the quality of life of patients with pancreatitis, improve the compliance with medical advice, and reduce the recurrence rate, but it needs to be further verified by a large sample, high-quality, multi-centered randomized controlled trial.

Objective: To investigate the effection of 10% glucose on laparoscopic cholecystectomy. Methods: Including 82 cases in patients undergoing laparoscopic cholecystectomy from June 2018 to November 2018 in the First Hospital of Lanzhou University. They were divided into the experimental group(40 cases) and the control group (42 cases) according to admission time. The control group used conventional nursing measures, fast day after 0:00. The experimental group took orally 400 ml 10% glucose solution on the night before surgery, 10% glucose 100 ml at 6:00 on the day. And then the perioperative safety, comfort and hospital satisfaction were observed. Results: No postoperative nausea and vomiting and complications occurred in the two groups. The perioperative satisfaction score of the experimental group was greater than the control group, which was 94.00±3.08 and 80.00±11.54 points, respectively, and the difference was statistically significant (t=3.45, P<0.01). The VAS scores of thirst, hunger, fatigue and anxiety in the experimental group were 2.97±3.55, 1.50±0.57, 2.50±1.00, 2.25±0.96, respectively, which were lower than those in the control group (3.55±2.98, 2.25±0.50, 5.50±0.57, 5.25±1.89), and the differences were statistically significant (t= 2.83-5.19, P<0.01 or 0.05). The VAS scores of thirst, hunger and fatigue in the experimental group were 3.60±1.00, 3.50±0.56, 2.75±1.50, respectively, 4 h after surgery, which were lower than those in the control group (7.00±0.58, 4.75 ±1.25, 5.75±0.50), with statistically significant differences (t=5.00, 3.69, 3.79, P<0.05). Compared with preoperative situation, the thirst and hunger degree of the two group both increased after surgery, while the anxiety degree of the control group decreased, and the difference was statistically significant (t=-9.91-5.20, P<0.05 or 0.01). Conclusions Oral administration of 10% glucose solution before laparoscopic cholecystectomy is safe and effective, which can improve perioperative comfort and hospitalization satisfaction of patients.